Brand  (β version)

  The number of atoms exceeds 100,000.
  So, it can not be displayed here.

Select unit:

Select hetatm:   

close
information
centroid:
interaction residue:

Select chain:   Sequence  

Data format:   

Color scheme of protein:

Ligands
Code Name Style Show Link
JZG 3-{1-[3-(biphenyl-4-ylamino)-3-oxopropyl]-1h-1,2,3-triazol-4-yl}-6-hydroxy-1-methyl-2-phenyl-1h-indole-5-carboxylic acid
Non-standard Residues
Code Name Show
Glycosylation
Code Name Emphasize
Modification
Code Name Show
Code : 3O5X   PDBj   RCSB PDB   PDBe
Header : HYDROLASE
Title : Crystal structure of the oncogenic tyrosine phosphatase SHP2 complexed with a salicylic acid-based small molecule inhibitor
Release Data : 2010-08-11
Compound :
mol_id molecule chains synonym
1 Tyrosine-protein phosphatase non-receptor type 11 A Protein-tyrosine phosphatase 2C, PTP-2C, Protein-tyrosine phosphatase 1D, PTP-1D, SH-PTP3, SH-PTP2, SHP-2, Shp2
ec: 3.1.3.48
fragment: UNP RESIDUES 262-532, CATALYTIC DOMAIN
Source :
mol_id organism_scientific organism_common
1 Homo sapiens  (taxid:9606) Human
Authors : Zhang, Z.-Y., Zhang, X., He, Y., Liu, S., Yu, Z., Jiang, Z., Yang, Z., Dong, Y., Nabinger, S.C., Wu, L., Gunawan, A.M., Wang, L., Chan, R.J.
Keywords : SHP2-IIB-08 complex, inhibitor, binding affinity, binding selectivity, receptor, Hydrolase, Dephosphorylation
Exp. method : X-RAY DIFFRACTION ( 2.0 Å )
Citation :

Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2).

Zhang, X.,He, Y.,Liu, S.  et al.
(2010)  J.Med.Chem.  53 : 2482 - 2493

PubMed: 20170098
DOI: 10.1021/jm901645u

Chain : A
UniProt : Q06124 (PTN11_HUMAN)
Reaction: EC: Evidence:
Physiological Direction:
H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] + phosphate 3.1.3.48 PROSITE- ProRule:PRU10044, PubMed:20170098, PubMed:26742426, PubMed:28074573
-